SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Richter MN. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol. 1928; 4: 285292.
  • 2
    Lortholary P, Boiron M, Ripault J, Levy JP, Manus A, Bernard J. Chronic lymphoid leukemia secondarily associated with a malignant reticulopathy: Richter's syndrome. Nouv Rev Fr Hematol. 1964; 78: 621644.
  • 3
    Brecher M, Banks PM. Hodgkin's disease variant of Richter's syndrome. Report of eight cases. Am J Clin Pathol. 1990; 93: 333339.
  • 4
    Litz CE, Arthur DC, Gajl-Peczalska KJ, et al. Transformation of chronic lymphocytic leukemia to small non-cleaved cell lymphoma: a cytogenetic, immunological, and molecular study. Leukemia. 1991; 5: 972978.
  • 5
    Pistoia V, Roncella S, Di Celle PF,et al. Emergence of a B-cell lymphoblastic lymphoma in a patient with B-cell chronic lymphocytic leukemia: evidence for the single-cell origin of the two tumors. Blood. 1991; 78: 797804.
  • 6
    Duchayne E, Delsol G, Kuhlein E, et al. Hairy cell transformation of a B-cell chronic lymphocytic leukemia: a morphological, cytochemical, phenotypic and molecular study. Leukemia. 1991; 5: 150155.
  • 7
    Strickler JG, Amsden TW, Kurtin PJ. Small B-cell lymphoid neoplasms with coexisting T-cell lymphomas. Am J Clin Pathol. 1992; 98: 424429.
  • 8
    Lee A, Skelly ME, Kingma DW, Medeiros LJ. B-cell chronic lymphocytic leukemia followed by high grade T-cell lymphoma. An unusual variant of Richter's syndrome. Am J Clin Pathol. 1995; 103: 348352.
  • 9
    Robertson LE, Pugh W, O'Brien S, et al. Richter's syndrome: a report on 39 patients. J Clin Oncol. 1993; 11: 19851989.
  • 10
    Dabaja BS, O'Brien SM, Kantarjian HM, et al. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone regimen in Richter's syndrome. Leuk Lymphoma. 2001; 42: 329337.
  • 11
    Tsimberidou AM, Kantarjian HM, Cortes J, et al. Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia. Cancer. 2003; 97: 17111720.
  • 12
    Tsimberidou AM, O'Brien SM, Cortes JE, et al. Phase II study of fludarabine, cytarabine, cyclophosphamide, cisplatin and GM-CSF in patients with Richter's syndrome or refractory lymphoproliferative disorders. Leuk Lymphoma. 2002; 43: 767772.
  • 13
    Harousseau JL, Flandrin G, Tricot G, Brouet JC, Seligmann M, Bernard J. Malignant lymphoma supervening in chronic lymphocytic leukemia and related disorders. Richter's syndrome: a study of 25 cases. Cancer. 1981; 48: 13021308.
  • 14
    Cherepakhin V, Baird SM, Meisenholder GW, Kipps TJ. Common clonal origin of chronic lymphocytic leukemia and high-grade lymphoma of Richter's syndrome. Blood. 1993; 82: 31413147.
  • 15
    Traweek ST, Liu J, Johnson RM, Winberg CD, Rappaport H. High-grade transformation of chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma. Genotypic confirmation of clonal identity. Am J Clin Pathol. 1993; 100: 519526.
  • 16
    Bernard DJ, Bignon YJ, Pauchard J, et al. Genotypic analyses of Richter's syndrome. Cancer. 1991; 67: 9971002.
  • 17
    Miyamura K, Osada H, Yamauchi T, et al. Single clonal origin of neoplastic B-cells with different immunoglobulin light chains in a patient with Richter's syndrome. Cancer. 1990; 66: 140144.
  • 18
    Schots R, Dehou MF, Jochmans K, et al. Southern blot analysis in a case of Richter's syndrome. Evidence for a postrearrangement heavy chain gene deletion associated with the altered phenotype. Am J Clin Pathol. 1991; 95: 571577.
  • 19
    Cofrancesco E, Baldini L, Ciani A, et al. Evidence of clonal progression in a case of Richter syndrome. Cancer. 1993; 71: 741744.
  • 20
    Koduru PR, Lichtman SM, Smilari TF, et al. Serial phenotypic, cytogenetic and molecular genetic studies in Richter's syndrome: demonstration of lymphoma development from the chronic lymphocytic leukaemia cells. Br J Haematol. 1993; 85: 613616.
  • 21
    Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of the diverse evolution of Richter's syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood. 1994; 83: 13631372.
  • 22
    Nakamine H, Masih AS, Sanger WG, et al. Richter's syndrome with different immunoglobulin light chain types. Molecular and cytogenetic features indicate a common clonal origin. Am J Clin Pathol. 1992; 97: 656663.
  • 23
    Brousse N, Solal-Celigny P, Herrera A, et al. Gastrointestinal Richter's syndrome. Hum Pathol. 1985; 16: 854857.
  • 24
    Kerim S, Geuna M, Francia di Celle P, et al. Heterogeneous immunoglobulin gene rearrangement in a B-chronic lymphocytic leukemia progressing into non-Hodgkin lymphoma (Richter syndrome). Cancer. 1993; 71: 359363.
  • 25
    Ott MM, Ott G, Roblick U, et al. Localized gastric non-Hodgkin's lymphoma of high-grade malignancy in patients with pre-existing chronic lymphocytic leukemia or immunocytoma. Leukemia. 1995; 9: 609614.
  • 26
    Sun T, Susin M, Desner M, Pergolizzi R, Cuomo J, Koduru P. The clonal origin of two cell populations in Richter's syndrome. Hum Pathol. 1990; 21: 722728.
  • 27
    Tohda S, Morio T, Suzuki T, et al. Richter syndrome with two B cell clones possessing different surface immunoglobulins and immunoglobulin gene rearrangements. Am J Hematol. 1990; 35: 3236.
  • 28
    Chubachi A, Ohtani H, Sakuyama M, et al. Diffuse large cell lymphoma occurring in a patient with Waldenstrom's macroglobulinemia. Evidence for the two different clones in Richter's syndrome. Cancer. 1991; 68: 781785.
  • 29
    Kruger A, Sadullah S, Chapman R, et al. Use of a retinoblastoma gene probe to investigate clonality in Richter's syndrome. Leukemia. 1993; 7: 18911895.
  • 30
    Matolcsy A. High-grade transformation of low-grade non-Hodgkin's lymphomas: mechanisms of tumor progression. Leuk Lymphoma. 1999; 34: 251259.
  • 31
    Muller-Hermelink HK, Zettl A, Pfeifer W, Ott G. Pathology of lymphoma progression. Histopathology. 2001; 38: 285306.
  • 32
    Brynes RK, McCourty A, Sun NC, Koo CH. Trisomy 12 in Richter's transformation of chronic lymphocytic leukemia. Am J Clin Pathol. 1995; 104: 199203.
  • 33
    Qian L, Gong J, Liu J, Broome JD, Koduru PR. Cyclin D2 promoter disrupted by t(12;22)(p13;q11.2) during transformation of chronic lymphocytic leukaemia to non-Hodgkin's lymphoma. Br J Haematol. 1999; 106: 477485.
  • 34
    Bea S, Lopez-Guillermo A, Ribas M, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol. 2002; 161: 957968.
  • 35
    Dierlamm J, Michaux L, Criel A, Wlodarska I, Van den Berghe H, Hossfeld DK. Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications. Cancer Genet Cytogenet. 1997; 94: 2735.
  • 36
    Hernandez JM, Mecucci C, Criel A, et al. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia. 1995; 9: 21402146.
  • 37
    Criel A, Wlodarska I, Meeus P, et al. Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. Br J Haematol. 1994; 87: 523528.
  • 38
    Que TH, Marco JG, Ellis J, et al. Trisomy 12 in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: analysis by stage, immunophenotype, and morphology. Blood. 1993; 82: 571575.
  • 39
    Matutes E, Oscier D, Garcia-Marco J, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol. 1996; 92: 382388.
  • 40
    Han T, Sadamori N, Ozer H, et al. Cytogenetic studies in 77 patients with chronic lymphocytic leukemia: correlations with clinical, immunologic, and phenotypic data. J Clin Oncol. 1984; 2: 11211132.
  • 41
    Han T, Henderson ES, Emrich LJ, Sandberg AA. Prognostic significance of karyotypic abnormalities in B cell chronic lymphocytic leukemia: an update. Semin Hematol. 1987; 24: 257263.
  • 42
    Zhu Y, Monni O, Franssila K, et al. Deletions at 11q23 in different lymphoma subtypes. Haematologica. 2000; 85: 908912.
  • 43
    Kobayashi H, Espinosa R 3rd, Fernald AA, et al. Analysis of deletions of the long arm of chromosome 11 in hematologic malignancies with fluorescence in situ hybridization. Genes Chromosome Cancer. 1993; 8: 246252.
  • 44
    Fegan C, Robinson H, Thompson P, Whittaker JA, White D. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 11q and advanced or progressive disease. Leukemia. 1995; 9: 20032008.
  • 45
    Cuneo A, Balboni M, Piva N, et al. Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation. Br J Haematol. 1995; 90: 409416.
  • 46
    Cobo F, Martinez A, Pinyol M, et al. Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemia. Leukemia. 2002; 16: 10281034.
  • 47
    Cuneo A, de Angeli C, Roberti MG, et al. Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation. Br J Haematol. 1996; 92: 375381.
  • 48
    Volpe G, Gamberi B, Pastore C, et al. Analysis of microsatellite instability in chronic lymphoproliferative disorders. Ann Hematol. 1996; 72: 6771.
  • 49
    Fulop Z, Csernus B, Timar B, Szepesi A, Matolcsy A. Microsatellite instability and hMLH1 promoter hypermethylation in Richter's transformation of chronic lymphocytic leukemia. Leukemia. 2003; 17: 411415.
  • 50
    Sanz-Vaque L, Colomer D, Bosch F, et al. Microsatellite instability analysis in typical and progressed mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Haematologica. 2001; 86: 181186.
  • 51
    Lee JN, Giles F, Huh YO, et al. Molecular differences between small and large cells in patients with chronic lymphocytic leukemia. Eur J Haematol. 2003; 71: 235242.
  • 52
    Gaidano G, Ballerini P, Gong JZ, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA. 1991; 88: 54135417.
  • 53
    Ichikawa A, Hotta T, Takagi N, et al. Mutations of p53 gene and their relation to disease progression in B-cell lymphoma. Blood. 1992; 79: 27012717.
  • 54
    Pinyol M, Cobo F, Bea S, et al. p16(INK4a) gene inactivation by deletions, mutations, and hypermethylation is associated with transformed and aggressive variants of non-Hodgkin's lymphomas. Blood. 1998; 91: 29772984.
  • 55
    Torelli UL, Torelli GM, Emilia G, et al. Simultaneously increased expression of the c-myc and mu chain genes in the acute blastic transformation of a chronic lymphocytic leukaemia. Br J Haematol. 1987; 65: 165170.
  • 56
    Arranz E, Martinez B, Richart A, et al. Increased C-MYC oncogene copy number detected with combined modified comparative genomic hybridization and FISH analysis in a Richter syndrome case with complex karyotype. Cancer Genet Cytogenet. 1998; 106: 8083.
  • 57
    Golay J, Luppi M, Songia S, et al. Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias. Blood. 1996; 87: 19001911.
  • 58
    Cordone I, Matutes E, Catovsky D. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity. Leukemia. 1992; 6: 902906.
  • 59
    Serrano M, Gomez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science. 1995; 267: 249252.
  • 60
    Nishikawa R, Furnari FB, Lin H, et al. Loss of P16INK4 expression is frequent in high grade gliomas. Cancer Res. 1995; 55: 19411945.
  • 61
    Okamoto A, Hussain SP, Hagiwara K, et al. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res. 1995; 55: 14481451.
  • 62
    Reed JA, Loganzo F Jr. Shea CR, et al. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995; 55: 27132718.
  • 63
    Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell. 1996; 85: 2737.
  • 64
    el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75: 817825.
  • 65
    Huang YQ, Li JJ, Karpatkin S. Thrombin inhibits tumor cell growth in association with up-regulation of p21(waf/cip1) and caspases via a p53-independent, STAT-1-dependent pathway. J Biol Chem. 2000; 275: 64626468.
  • 66
    Polyak K, Lee MH, Erdjument-Bromage H, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell. 1994; 78: 5966.
  • 67
    Morosetti R, Kawamata N, Gombart AF, et al. Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood. 1995; 86: 19241930.
  • 68
    Ginsberg AM, Raffeld M, Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood. 1991; 77: 833840.
  • 69
    Martinez JC, Piris MA, Sanchez-Beato M, et al. Retinoblastoma (Rb) gene product expression in lymphomas. Correlation with Ki67 growth fraction. J Pathol. 1993; 169: 405412.
  • 70
    Weide R, Tiemann M, Pfluger KH, et al. Altered expression of the retinoblastoma gene product in human high grade non-Hodgkin's lymphomas. Leukemia. 1994; 8: 97101.
  • 71
    Gratama JW, Ernberg I. Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res. 1995; 67: 197255.
  • 72
    Tosato G, Blaese RM. Epstein-Barr virus infection and immunoregulation in man. Adv Immunol. 1985; 37: 99149.
  • 73
    Rickinson A. Cellular immunologic responses to the virus infection. In: EpsteinMA, AchongBG, editors. Epstein-Barr virus: recent advances. London: William Heinemann Medical Books Ltd., 1986: 75125.
  • 74
    Khan G, Norton AJ, Slavin G. Epstein-Barr virus in Reed-Sternberg-like cells in non-Hodgkin's lymphomas. J Pathol. 1993; 169: 914.
  • 75
    Foon KA, Thiruvengadam R, Saven A, Bernstein ZP, Gale RP. Genetic relatedness of lymphoid malignancies. Transformation of chronic lymphocytic leukemia as a model. Ann Intern Med. 1993; 119: 6373.
  • 76
    Rickinson AB. Epstein-Barr virus in action in vivo. N Engl J Med. 1998; 338: 14611463.
  • 77
    Neri A, Barriga F, Inghirami G, et al. Epstein-Barr virus infection precedes clonal expansion in Burkitt's and acquired immunodeficiency syndrome-associated lymphoma. Blood. 1991; 77: 10921095.
  • 78
    Rickinson A. Concluding overview: looking back, looking forward. Philos Trans R Soc Lond B Biol Sci. 2001; 356: 595604.
  • 79
    Cohen JI. Epstein-Barr virus lymphoproliferative disease associated with acquired immunodeficiency. Medicine. 1991; 70: 137160.
  • 80
    Paya CV, Fung JJ, Nalesnik MA, et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation. 1999; 68: 15171525.
  • 81
    Riddler SA, Breinig MC, McKnight JL. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood. 1994; 84: 972984.
  • 82
    Tosato G, Jones K, Breinig MK, McWilliams HP, McKnight JL. Interleukin-6 production in posttransplant lymphoproliferative disease. J Clin Invest. 1993; 91: 28062814.
  • 83
    Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res. 2004; 10: 803821.
  • 84
    Kieff E, Leibowitz D. Oncogenesis by herpesvirus. In: WeinbergRA, editor. Oncogenes and the molecular origin of cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989: 259280.
  • 85
    Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986; 47: 883889.
  • 86
    Rickinson AB, Moss DJ. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu Rev Immunol. 1997; 15: 405431.
  • 87
    Ballerini P, Gaidano G, Gong JZ, et al. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood. 1993; 81: 166176.
  • 88
    Hamilton-Dutoit SJ, Pallesen G. A survey of Epstein-Barr virus gene expression in sporadic non-Hodgkin's lymphomas. Detection of Epstein-Barr virus in a subset of peripheral T-cell lymphomas. Am J Pathol. 1992; 140: 13151325.
  • 89
    Carbone A, Gaidano G, Gloghini A, et al. BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression. Am J Pathol. 1997; 150: 155165.
  • 90
    Niedobitek G, Young LS, Herbst H. Epstein-Barr virus infection and the pathogenesis of malignant lymphomas. Cancer Surv. 1997; 30: 143162.
  • 91
    Kuppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999; 341: 15201529.
  • 92
    Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell. 1995; 80: 389399.
  • 93
    Kaye KM, Devergne O, Harada JN, et al. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc Natl Acad Sci U S A. 1996; 93: 1108511090.
  • 94
    Devergne O, Hatzivassiliou E, Izumi KM, et al. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol. 1996; 16: 70987108.
  • 95
    Liebowitz D, Mannick J, Takada K, Kieff E. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. J Virol. 1992; 66: 46124616.
  • 96
    Liebowitz D. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients. N Engl J Med. 1998; 338: 14131421.
  • 97
    Ansell SM, Li CY, Lloyd RV, Phyliky RL. Epstein-Barr virus infection in Richter's transformation. Am J Hematol. 1999; 60: 99104.
  • 98
    Momose H, Jaffe ES, Shin SS, Chen YY, Weiss LM. Chronic lymphocytic leukemia/small lymphocytic lymphoma with Reed-Sternberg-like cells and possible transformation to Hodgkin's disease. Mediation by Epstein-Barr virus. Am J Surg Pathol. 1992; 16: 859867.
  • 99
    Petrella T, Yaziji N, Collin F, et al. Implication of the Epstein-Barr virus in the progression of chronic lymphocytic leukaemia/small lymphocytic lymphoma to Hodgkin-like lymphomas. Anticancer Res. 1997; 17(5B): 39073913.
  • 100
    Rubin D, Hudnall SD, Aisenberg A, Jacobson JO, Harris NL. Richter's transformation of chronic lymphocytic leukemia with Hodgkin's-like cells is associated with Epstein-Barr virus infection. Mod Pathol. 1994; 7: 9198.
  • 101
    Pescarmona E, Pignoloni P, Mauro FR, et al. Hodgkin/Reed-Sternberg cells and Hodgkin's disease in patients with B-cell chronic lymphocytic leukaemia: an immunohistological, molecular and clinical study of four cases suggesting a heterogeneous pathogenetic background. Virchows Arch. 2000; 437: 129132.
  • 102
    Fagard R, Mouas H, Dusanter-Fourt I, et al. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells. Oncogene. 2002; 21: 44734480.
  • 103
    Henderson S, Rowe M, Gregory C, et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell. 1991; 65: 11071115.
  • 104
    Rowe M, Peng-Pilon M, Huen DS, et al. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers. J Virol. 1994; 68: 56025612.
  • 105
    Saad ED, Thomas DA, O'Brien S, et al. Progressive multifocal leukoencephalopathy with concurrent Richter's syndrome. Leuk Lymphoma. 2000; 38(1–2): 183190.
  • 106
    Armitage JO, Dick FR, Corder MP. Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer. 1978; 41: 422427.
  • 107
    Jelic S, Jovanovic V, Milanovic N, et al. Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia. Neoplasma. 1997; 44: 6368.
  • 108
    Belsito VP, Iaccarino S, Liguori L, et al. Chronic lymphocytic leukemia in Richter's transformation: our experience [abstract]. Blood. 1999; 94( Suppl. 1): 295b.
  • 109
    Desablens B, Garidi R, Fernandez J, Capiod JC, Legrand S, Tabuteau S. Does fludarabine increase the risk of Richter's syndrome (RS) among chronic lymphocytic leukemia? [abstract]. Haematologica. 1999; 84: 259.
  • 110
    Morrison VA, Rai KR, Peterson BL, et al. Transformation to Richter's syndrome or prolymphocytic leukemia (PLL): an Intergroup study (CALGB 9011) [abstract]. Blood. 1999; 94( Suppl. 1): 539a.
  • 111
    Mauro FR, Foa R, Giannarelli D, et al. Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood. 1999; 94: 448454.
  • 112
    Tabuteau S, Fernandez J, Garidi R, Desablens B. Richter's syndrome in B-CLL: report of 37 cases [abstract]. Blood. 1999; 34( Suppl. 1): 306b.
  • 113
    Trump DL, Mann RB, Phelps R, Roberts H, Conley CL. Richter's syndrome: diffuse histiocytic lymphoma in patients with chronic lymphocytic leukemia. A report of five cases and review of the literature. Am J Med. 1980; 68: 539548.
  • 114
    Foucar K, Rydell RE. Richter's syndrome in chronic lymphocytic leukemia. Cancer. 1980; 46: 118134.
  • 115
    Long JC, Aisenberg AC. Richter's syndrome. A terminal complication of chronic lymphocytic leukemia with distinct clinicopathologic features. Am J Clin Pathol. 1975; 63: 786795.
  • 116
    Parrens M, Sawan B, Dubus P, et al. Primary digestive Richter's syndrome. Mod Pathol. 2001; 14: 452457.
  • 117
    Givler RL. Lymphocytic leukemia with coexistent localized reticulum cell sarcoma. Cancer. 1968; 21: 11841192.
  • 118
    Jasani B, Gough J, Myers K, Wells AL. Gastrointestinal Richter's syndrome. Hum Pathol. 1986; 17: 1184.
  • 119
    Desablens B, Gineston JL, Joly JP, Piprot-Choffat C, Sevestre H, Capron JP. Lymphome immunoblastique de la region ileo-caecale au cours d'une leucemie lymphoide chronique. Syndrome de Richter localise a l'intestin et revele par une ascite (Immunoblastic lymphoma of the ileocecal region in chronic lymphocytic leukemia). Richter's syndrome localized in the intestine and disclosed by ascites. Gastroenterol Clin Biol. 1987; 11: 901903.
  • 120
    Faigel DO, Vaughn DJ, Furth EE, Metz DC. Chronic lymphocytic leukemia: an unusual cause of upper gastrointestinal hemorrhage. Am J Gastroenterol. 1995; 90: 635637.
  • 121
    Fraitag S, Bodemer C, Rousselot P, et al. Transformation cutanee d'une leucemie lymphoide chronique en lymphome immunoblastique. Presentation cutanee d'un syndrome de Richter [Cutaneous transformation of chronic lymphoid leukemia into immunoblastic lymphoma. Cutaneous manifestation of Richter's syndrome]. Ann Dermatol Venereol. 1995; 122: 530533.
  • 122
    Mahe B, Moreau P, Bonnemain B, et al. Isolated Richter's syndrome of the brain: two recent cases. Nouv Rev Fr Hematol. 1994; 36: 383385.
  • 123
    Bayliss KM, Kueck BD, Hanson CA, Matthaeus WG, Almagro UA. Richter's syndrome presenting as primary central nervous system lymphoma. Transformation of an identical clone. Am J Clin Pathol. 1990; 93: 117123.
  • 124
    Wilson JA. Richter's syndrome mimicking chronic colitis. A patient with diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Dis Colon Rectum. 1986; 29: 191195.
  • 125
    O'Neill BP, Habermann TM, Banks PM, O'Fallon JR, Earle JD. Primary central nervous system lymphoma as a variant of Richter's syndrome in two patients with chronic lymphocytic leukemia. Cancer. 1989; 64: 12961300.
  • 126
    Zarco C, Lahuerta-Palacios JJ, Borrego L, Toscano R, Gil R, Iglesias L. Centroblastic transformation of chronic lymphocytic leukaemia with primary skin involvement—cutaneous presentation of Richter's syndrome. Clin Exp Dermatol. 1993; 18: 263267.
  • 127
    Hattenhauer MG, Pach JM. Ocular lymphoma in a patient with chronic lymphocytic leukemia. Am J Ophthalmol. 1996; 122: 266268.
  • 128
    Houdelette P, Dumotier J, Hauteville D, Pierre C, Berthod N. Syndrome de Richter a localisation testiculaire [Richter's syndrome with testicular localization]. J Urol (Paris). 1989; 95: 507508.
  • 129
    Alliot C, Tabuteau S, Desablens B. Hodgkin's disease variant of Richter's syndrome: complete remission of the both malignancies after 14 years. Hematology. 2003; 8: 229231.
  • 130
    Juneja S, Carney D, Ellis D, Januszewicz EH, Wolf M, Prince HM. Hodgkin's disease type of Richter's syndrome in chronic lymphocytic leukemia. Leukemia. 1999; 13: 826827.
  • 131
    Robak T, Szmigielska-Kaplon A, Smolewski P, et al. Hodgkin's type of Richter's syndrome in familial chronic lymphocytic leukemia treated with cladribine and cyclophosphamide. Leuk Lymphoma. 2003; 44: 859866.
  • 132
    Fayad L, Robertson LE, O'Brien S, et al. Hodgkin's disease variant of Richter's syndrome: experience at a single institution. Leuk Lymphoma. 1996; 23(3–4): 333337.
  • 133
    Weisenberg E, Anastasi J, Adeyanju M, Variakojis D, Vardiman JW. Hodgkin's disease associated with chronic lymphocytic leukemia. Eight additional cases, including two of the nodular lymphocyte predominant type. Am J Clin Pathol. 1995; 103: 479484.
  • 134
    Seymour J, Campbell J. Richter's syndrome. In: ChesonBD, editor. Chronic lymphoid leukemias New York: Marcel Dekker, 2001: 459483.
  • 135
    Beaudreuil J, Lortholary O, Martin A, et al. Hypercalcemia may indicate Richter's syndrome: report of four cases and review. Cancer. 1997; 79: 12111215.
  • 136
    Briones J, Cervantes F, Montserrat E, Rozman C. Hypercalcemia in a patient with chronic lymphocytic leukemia evolving into Richter's syndrome. Leuk Lymphoma. 1996; 21(5–6): 521523.
  • 137
    Partyka S, O'Brien S, Podoloff D, Kantarjian H, Keating MJ. The usefulness of high dose (7-10 mci) gallium (67Ga) scanning to diagnose Richter's transformation. Leuk Lymphoma. 1999; 36(1–2): 151155.
  • 138
    Cobo F, Rosinol L, Martinez A, et al. Limitations of Gallium-67 SPECT in histological transformation of chronic lymphocytic leukaemia: an analysis of 13 patients with clinically suspected Richter's syndrome. Br J Haematol. 2002; 119: 484487.
  • 139
    Atlas SW, Lavi E, Fisher GP. Intraaxial brain tumors. In: AtlasSW, editor. Magnetic resonance imaging of the brain and spine. Philadelphia: Lippincott Williams nad Wilkins, 2002: 565693.
  • 140
    Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood. 1975; 46: 219234.
  • 141
    Pugh WC, Manning JT, Butler JJ. Paraimmunoblastic variant of small lymphocytic lymphoma/leukemia. Am J Surg Pathol. 1988; 12: 907917.
  • 142
    Matolcsy A, Schattner EJ, Knowles DM, Casali P. Clonal evolution of B cells in transformation from low- to high-grade lymphoma. Eur J Immunol. 1999; 29: 12531264.
  • 143
    van Dongen JJ, Hooijkaas H, Michiels JJ, et al. Richter's syndrome with different immunoglobulin light chains and different heavy chain gene rearrangements. Blood. 1984; 64: 571575.
  • 144
    van Endert PM, Mechtersheimer G, Moller P, Dorken B, Hammerling GJ, Moldenhauer G. Discordant differentiation antigen pattern in a case of Richter's syndrome with monoclonal idiotype expression and immunoglobulin gene rearrangement. Br J Cancer. 1990; 62: 248252.
  • 145
    Williams J, Schned A, Cotelingam JD, Jaffe ES. Chronic lymphocytic leukemia with coexistent Hodgkin's disease. Implications for the origin of the Reed-Sternberg cell. Am J Surg Pathol. 1991; 15: 3342.
  • 146
    Shin SS, Ben-Ezra J, Burke JS, Sheibani K, Rappaport H. Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage. Am J Clin Pathol. 1993; 99: 658662.
  • 147
    Tsang WY, Chan JK, Sing C. The nature of Reed-Sternberg-like cells in chronic lymphocytic leukemia. Am J Clin Pathol. 1993; 99: 317323.
  • 148
    Choi H, Keller RH. Coexistence of chronic lymphocytic leukemia and Hodgkin's disease. Cancer. 1981; 48: 4857.
  • 149
    Hansmann ML, Fellbaum C, Hui PK, Lennert K. Morphological and immunohistochemical investigation of non-Hodgkin's lymphoma combined with Hodgkin's disease. Histopathology. 1989; 15: 3548.
  • 150
    Butts C, Drouin J, Taylor R, McLeish W. Hodgkin's disease in CLL. Am J Hematol. 1995; 48: 134135.
  • 151
    Cha I, Herndier BG, Glassberg AB, Hamill TR. A case of composite Hodgkin's disease and chronic lymphocytic leukemia in bone marrow. Lack of Epstein-Barr virus. Arch Pathol Lab Med. 1996; 120: 386389.
  • 152
    Ohno T, Smir BN, Weisenburger DD, Gascoyne RD, Hinrichs SD, Chan WC. Origin of the Hodgkin/Reed-Sternberg cells in chronic lymphocytic leukemia with “Hodgkin's transformation.” Blood. 1998; 91: 17571761.
  • 153
    Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response. J Clin Oncol. 1983; 1: 710719.
  • 154
    Rodriguez J, Keating MJ, O'Brien S, Champlin RE, Khouri IF. Allogeneic haematopoietic transplantation for Richter's syndrome. Br J Haematol. 2000; 110: 897899.
  • 155
    Espanol I, Buchler T, Ferra C, et al. Richter's syndrome after allogeneic stem cell transplantation for chronic lymphocytic leukaemia successfully treated by withdrawal of immunosuppression, and donor lymphocyte infusion. Bone Marrow Transplant. 2003; 31: 215218.
  • 156
    Rai KR, O'Brien S, Cunningham C, et al. Genasense (bcl-2 antisense) monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia: phase 1 and 2 results [abstract]. Blood. 2002; 100: 384a.
  • 157
    Tsimberidou AM, Murray JL, O'Brien S, Wierda WG, Keating MJ. Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome. Cancer. 2004; 100: 21952200.
  • 158
    Ng K, Nash J, Woodcock BE. High grade lymphoma of the cerebellum: a rare complication of chronic lymphatic leukaemia. Clin Lab Haematol. 1991; 13: 9397.
  • 159
    van Besien K, Ha CS, Murphy S, et al. Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma. Blood. 1998; 91: 11781184.